… most commonly prescribed and effective medications for the condition, methotrexate (MTX … can tell the doctors and healthcare team which drug treatment is most likely … al. Identification and validation of interferon-driven gene signature as a …

… discipline to the development of medicine, agriculture, industry, environmental protection … the Biological Research Center, where Interferon was conceived and produced. Five … Center for Genetic Engineering and Biotechnology (CIGB) was created by Commander …

… Pharmaceutical Review Committee (CPRC) during its deliberations on orphan drug … delivers the human interferon alfa-2b gene … clinical trial (NCT02773849) that supported FDA approval … delivery anticancer drug; with their different treatment mechanisms, …

… detection and quantitation of active pharmaceutical ingredients (APIs) and metabolites … receptor (CAR) T-cell treatments, oligonucleotide therapeutics, antibody drug conjugates (ADCs) and … Distribution of a Stimulator of Interferon Genes Agonist and Its …

… efficacy, and numerous trials are ongoing to explore … agents, or anti-cancer medications, (2) uncontrolled intercurrent … the first dose of trial treatment, (5) active autoimmune … interferon-gamma (IFN-γ) and interferon-alpha/beta signaling in treatment …

… , the Food and Drug Administration (FDA) expanded the approval of … efficacy of the older interferon-based therapy before the … FDA-approved for the treatment of acute hepatitis C, although some doctors … the Phase III M20-350 trial (NCT04903626), which enrolled …

… acting antiviral approved by the FDA for this condition. The … arm prospective phase 3 clinical trial that evaluated the efficacy … if they received prior treatment for HCV, including interferon, or had a … Sign up for our free Drug Topics newsletter and get the …

… fnia (Saphnelo), an anti–interferon-α antibody; afamelanotide (Scenesse … a phase 2b clinical trial (NCT03715829) of ritlecitinib … the novel immunomodulatory pharmaceuticals combined with nbUV … offering a combination of medical treatments, emotional support, and …

… cells bearing a type II interferon signature in those with ILD … cells with a type II interferon-stimulated gene signature. These T … systemic sclerosis. With few effective treatments currently available, the identification of …

… a nanotechnology-based oral drug carrier that makes it … diabetes, calcitonin for osteoporosis and interferon-alpha for cancer — safely … treatments. Peppas also has championed interdisciplinary collaboration, translating research into effective medical …